Enhanced BCR (22) and TLR (23) signaling, as well as interaction with stromal cells (24), have been proposed as the main source of aberrant NF-κB activation in CLL cells (25). This evidence concerns the gene NFKB1 and B-cell chronic lymphocytic leukemia.